These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29966778)

  • 1. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
    Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
    World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
    Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
    Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas.
    Zhenye L; Chuzhong L; Youtu W; Xiaolei L; Lei C; Lichuan H; Hongyun W; Yonggang W; Fei W; Yazhuo Z
    J Transl Med; 2014 Mar; 12():71. PubMed ID: 24636138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.
    Gu YH; Feng YG
    J Clin Neurosci; 2018 Jan; 47():264-268. PubMed ID: 29031543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
    Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
    World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt pathway inhibitors are strongly down-regulated in pituitary tumors.
    Elston MS; Gill AJ; Conaglen JV; Clarkson A; Shaw JM; Law AJ; Cook RJ; Little NS; Clifton-Bligh RJ; Robinson BG; McDonald KL
    Endocrinology; 2008 Mar; 149(3):1235-42. PubMed ID: 18079202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas.
    Yao X; Gao H; Li C; Wu L; Bai J; Wang J; Li Y; Zhang Y
    J Neurooncol; 2017 Apr; 132(2):199-206. PubMed ID: 28255749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
    Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
    World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
    Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
    Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Transforming Growth Factor β1, Smad3, and Phospho-Smad3 in Somatotropinomas and Their Relationship to Tumor Behavior.
    Li Z; Li J; Shan X; Gui S; Li C; Zhang Y
    World Neurosurg; 2021 Sep; 153():e20-e27. PubMed ID: 34087455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.
    Ramírez C; Cheng S; Vargas G; Asa SL; Ezzat S; González B; Cabrera L; Guinto G; Mercado M
    J Clin Endocrinol Metab; 2012 May; 97(5):1745-51. PubMed ID: 22419713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting recurrence of nonfunctioning pituitary adenomas.
    Noh TW; Jeong HJ; Lee MK; Kim TS; Kim SH; Lee EJ
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4406-13. PubMed ID: 19820025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA.
    Øystese KA; Casar-Borota O; Normann KR; Zucknick M; Berg JP; Bollerslev J
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3581-3590. PubMed ID: 28911153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas.
    Aylwin SJ; Welch JP; Davey CL; Geddes JF; Wood DF; Besser GM; Grossman AB; Monson JP; Burrin JM
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2476-83. PubMed ID: 11397843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
    Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
    Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.
    Wang M; Zhang H; Heng X; Pang Q; Sun A
    Med Sci Monit; 2015 May; 21():1256-60. PubMed ID: 25934796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
    Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
    J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased β‑catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach.
    Liu C; Wu Y; Yu S; Bai J; Li C; Wu D; Zhang Y
    Mol Med Rep; 2017 Apr; 15(4):1793-1799. PubMed ID: 28260015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.